Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections

• Main Authors: Ute Chiriac (Author), Uwe Liebchen (Author), Otto Roman Frey (Author), Heike Lanzinger (Author), Sabrina Klein (Author), Torsten Hoppe-Tichy (Author), Matthias Karck (Author), Anna Meyer (Author), Benedict Morath (Author)
• Format: Book
• Published: MDPI AG, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Increasing evidence suggests that dalbavancin is an effective long-term treatment for ventricular assist device (VAD) infections, with various prolonged dosing regimens currently in use. This retrospective study aimed to assess dalbavancin pharmacokinetics in VAD patients and identify optimal, feasi...